Prosecution Insights
Prosecution Insights
17 pending office actions • 14 art units • 17 examiners • 0 of 17 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (6%) |
| §101 + other | 1 (6%) |
| §103 only | 3 (18%) |
| §102 only | 2 (12%) |
| §112 only | 2 (12%) |
| Double-patenting only | 1 (6%) |
| Multi-statute (no §101) | 7 (41%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TOOHEY, RICHARD ORLANDO | 1 | 83.6% | +9.0% |
| PIPIC, ALMA | 1 | 54.3% | +55.2% |
| PAGE, BRENT T | 1 | 82.4% | +10.8% |
| SCHMITT, MICHAEL J | 1 | 56.6% | +21.7% |
| ARCIERO, ADAM A | 1 | 65.2% | -18.1% |
| HIRAKIS, SOPHIA P | 1 | 52.2% | +73.3% |
| HASTINGS, ALISON AZAR | 1 | 63.3% | +40.3% |
| BUTTICE, AUDREY L | 1 | 47.1% | +26.0% |
| MCCAIG, BRIAN A | 1 | 80.4% | +13.4% |
| PATEL, SAGAR S | 1 | 76.0% | +34.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553120 | CATALYST STRUCTURE FOR SYNTHESIS GAS PRODUCTION, SYNTHESIS GAS PRODUCTION DEVICE, AND METHOD FOR PRODUCING CATALYST STRUCTURE FOR SYNTHESIS GAS PRODUCTION | MCCAIG, BRIAN A | 60d |
| 18548731 | SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT | PAGE, BRENT T | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262326 | ANTI-VIRAL AGENT | PATEL, SAGAR S | 3d overdue |
| 18396305 | COPPER CHELATOR, ANTICANCER AGENT AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR WILSON'S DISEASE | HASTINGS, ALISON AZAR | 15d |
| 18106049 | SEMICONDUCTOR OPTICAL DEVICE AND METHOD OF MANUFACTURING THE SAME | PETKOVSEK, DANIEL | 22d |
| 18024955 | METHOD FOR DIAGNOSING NONALCOHOLIC STEATOHEPATITIS | BOWERS, ERIN M | 27d |
| 18879006 | FLUORESCENCE MICROSCOPE | TOOHEY, RICHARD ORLANDO | — |
| 18578874 | SULFIDE SOLID ELECTROLYTE | ARCIERO, ADAM A | — |
| 18154575 | JAPANESE ENCEPHALITIS PREVENTIVE AGENT AND JAPANESE ENCEPHALITIS VACCINE AGENT | QIAN, CELINE X | — |
| 18052100 | TREATMENT DEVICE | MORAN, EDWARD JOHN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262326 | ANTI-VIRAL AGENT | PATEL, SAGAR S | 3d overdue |
| 18396305 | COPPER CHELATOR, ANTICANCER AGENT AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR WILSON'S DISEASE | HASTINGS, ALISON AZAR | 15d |
| 18553120 | CATALYST STRUCTURE FOR SYNTHESIS GAS PRODUCTION, SYNTHESIS GAS PRODUCTION DEVICE, AND METHOD FOR PRODUCING CATALYST STRUCTURE FOR SYNTHESIS GAS PRODUCTION | MCCAIG, BRIAN A | 60d |
| 18851300 | LIPID NANOPARTICLES | PIPIC, ALMA | — |
| 18548731 | SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT | PAGE, BRENT T | — |
| 18692022 | BICYCLIC HETEROCYCLIC DERIVATIVE HAVING VIRAL GROWTH INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SCHMITT, MICHAEL J | — |
| 18396272 | COMPOUND, MANUFACTURING METHOD THEREFOR, ANTIMICROBIAL AGENT, AND MEDICINAL DRUG | HIRAKIS, SOPHIA P | — |
| 18259348 | GFRALPHA1-CONTAINING NEURITE OUTGROWTH PROMOTER AND PHARMACEUTICAL COMPOSITION FOR INDUCING NERVE REGENERATION | BUTTICE, AUDREY L | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1663 | 1 |
| 1629 | 1 |
| 1623 | 1 |
| 1627 | 1 |
| 1772 | 1 |
| 1626 | 1 |
| 1653 | 1 |
| 2874 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18879006 | FLUORESCENCE MICROSCOPE | TOOHEY, RICHARD ORLANDO | — | §102§103§112 | Non-Final OA | — | Pending | Dec 26, 2024 |
| 18851300 | LIPID NANOPARTICLES | PIPIC, ALMA | 1617 | DP | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18548731 | SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT | PAGE, BRENT T | 1663 | §112 | Final Rejection | — | Pending | Apr 24, 2024 |
| 18692022 | BICYCLIC HETEROCYCLIC DERIVATIVE HAVING VIRAL GROWTH INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SCHMITT, MICHAEL J | 1629 | §102 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18578874 | SULFIDE SOLID ELECTROLYTE | ARCIERO, ADAM A | — | §102§103 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18396272 | COMPOUND, MANUFACTURING METHOD THEREFOR, ANTIMICROBIAL AGENT, AND MEDICINAL DRUG | HIRAKIS, SOPHIA P | 1623 | §112 | Non-Final OA | — | Pending | Dec 26, 2023 |
| 18396305 | COPPER CHELATOR, ANTICANCER AGENT AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR WILSON'S DISEASE | HASTINGS, ALISON AZAR | 1627 | §101§102§103 | Non-Final OA | 15d | Pending | Dec 26, 2023 |
| 18259348 | GFRALPHA1-CONTAINING NEURITE OUTGROWTH PROMOTER AND PHARMACEUTICAL COMPOSITION FOR INDUCING NERVE REGENERATION | BUTTICE, AUDREY L | — | §103 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18553120 | CATALYST STRUCTURE FOR SYNTHESIS GAS PRODUCTION, SYNTHESIS GAS PRODUCTION DEVICE, AND METHOD FOR PRODUCING CATALYST STRUCTURE FOR SYNTHESIS GAS PRODUCTION | MCCAIG, BRIAN A | 1772 | §103 | Non-Final OA | 60d | Pending | Sep 28, 2023 |
| 18262326 | ANTI-VIRAL AGENT | PATEL, SAGAR S | 1626 | §102§103§112 | Non-Final OA | 3d overdue | Pending | Jul 20, 2023 |
| 18024955 | METHOD FOR DIAGNOSING NONALCOHOLIC STEATOHEPATITIS | BOWERS, ERIN M | 1653 | §101 | Final Rejection | 27d | Pending | Mar 06, 2023 |
| 18106049 | SEMICONDUCTOR OPTICAL DEVICE AND METHOD OF MANUFACTURING THE SAME | PETKOVSEK, DANIEL | 2874 | §102§103 | Non-Final OA | 22d | Pending | Feb 06, 2023 |
| 18154575 | JAPANESE ENCEPHALITIS PREVENTIVE AGENT AND JAPANESE ENCEPHALITIS VACCINE AGENT | QIAN, CELINE X | 1637 | §102§112 | Non-Final OA | — | Pending | Jan 13, 2023 |
| 18052100 | TREATMENT DEVICE | MORAN, EDWARD JOHN | 3772 | §102§103§112 | Final Rejection | — | Pending | Nov 02, 2022 |
| 17996070 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HOU, FRANK S | 1692 | §102 | Non-Final OA | — | Pending | Oct 12, 2022 |
| 17930920 | CATALYST, METHOD FOR PRODUCING ISOBUTYL ALDEHYDE AND METHACROLEIN, METHOD FOR PRODUCING METHACRYLIC ACID, AND METHOD FOR PRODUCING METHACRYLIC ACID ESTER | LI, JUN | 1732 | §102§103 | Non-Final OA | — | Pending | Sep 09, 2022 |
| 17802772 | BLOCK COPOLYMER AND METHOD FOR PRODUCING SAME | MCCULLEY, MEGAN CASSANDRA | 1767 | §103 | Final Rejection | — | Pending | Aug 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial